Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 20% ± 1% |
Insufficient scRNA-seq data for expression of TARS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1355.67 | 1445 / 1445 | 100% | 25.99 | 183 / 183 |
liver | 100% | 1752.00 | 226 / 226 | 100% | 35.61 | 406 / 406 |
ovary | 100% | 1468.86 | 180 / 180 | 100% | 34.17 | 430 / 430 |
skin | 100% | 1707.91 | 1809 / 1809 | 100% | 47.30 | 472 / 472 |
breast | 100% | 1457.04 | 459 / 459 | 100% | 50.05 | 1117 / 1118 |
thymus | 100% | 1481.44 | 653 / 653 | 100% | 27.62 | 604 / 605 |
uterus | 100% | 1358.47 | 170 / 170 | 100% | 39.39 | 458 / 459 |
brain | 100% | 1518.86 | 2636 / 2642 | 100% | 34.63 | 705 / 705 |
stomach | 100% | 1214.65 | 359 / 359 | 100% | 28.92 | 285 / 286 |
prostate | 100% | 1325.92 | 245 / 245 | 100% | 26.84 | 500 / 502 |
kidney | 100% | 1297.09 | 89 / 89 | 100% | 27.40 | 897 / 901 |
bladder | 100% | 1393.00 | 21 / 21 | 99% | 35.50 | 501 / 504 |
intestine | 100% | 1268.93 | 965 / 966 | 99% | 29.87 | 524 / 527 |
lung | 99% | 1085.25 | 572 / 578 | 100% | 32.90 | 1155 / 1155 |
adrenal gland | 100% | 2361.23 | 258 / 258 | 99% | 22.07 | 227 / 230 |
pancreas | 99% | 820.05 | 325 / 328 | 99% | 26.26 | 176 / 178 |
adipose | 100% | 1294.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 30.58 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.86 | 29 / 29 |
muscle | 100% | 2234.60 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1941.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.81 | 1 / 1 |
blood vessel | 100% | 972.81 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1503.35 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 1263.10 | 821 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0106074 | Biological process | aminoacyl-tRNA metabolism involved in translational fidelity |
GO_0006435 | Biological process | threonyl-tRNA aminoacylation |
GO_0070159 | Biological process | mitochondrial threonyl-tRNA aminoacylation |
GO_0005575 | Cellular component | cellular_component |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0002161 | Molecular function | aminoacyl-tRNA editing activity |
GO_0004829 | Molecular function | threonine-tRNA ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | TARS2 |
Protein name | Threonyl-tRNA synthetase 2, mitochondrial threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1) Threonyl-tRNA synthetase 2 |
Synonyms | TARSL1 |
Description | FUNCTION: Catalyzes the attachment of threonine to tRNA(Thr) in a two-step reaction: threonine is first activated by ATP to form Thr-AMP and then transferred to the acceptor end of tRNA(Thr). Also edits incorrectly charged tRNA(Thr) via its editing domain. . |
Accessions | U3KQG0 Q5T5E9 ENST00000369064.8 [Q9BW92-1] ENST00000369051.7 U3KQ50 Q9BW92 ENST00000467982.6 ENST00000606933.5 A0A810V332 A0A810V1V9 ENST00000369054.6 [Q9BW92-2] |